BMRN
Biomarin Pharmaceutical Inc
Price:  
91.24 
USD
Volume:  
3,632,248.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin WACC - Weighted Average Cost of Capital

The WACC of Biomarin Pharmaceutical Inc (BMRN) is 8.4%.

The Cost of Equity of Biomarin Pharmaceutical Inc (BMRN) is 8.75%.
The Cost of Debt of Biomarin Pharmaceutical Inc (BMRN) is 4.35%.

Range Selected
Cost of equity 7.40% - 10.10% 8.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 4.70% 4.35%
WACC 7.1% - 9.7% 8.4%
WACC

Biomarin WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 10.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.06 0.06
Cost of debt 4.00% 4.70%
After-tax WACC 7.1% 9.7%
Selected WACC 8.4%